chr6-89567064-A-C

Position:

• chr6-89567064-A-C

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_001242809.2(ANKRD6):​c.88A>C​(p.Ile30Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

• Frequency: Genomes: not found (cov: 33)
• Consequence: ANKRD6 NM_001242809.2 missense
• Clinical Significance: Uncertain significance criteria provided, single submitter U:1
• Conservation: PhyloP100: 8.86

Genes affected

ANKRD6 (HGNC:17280): (ankyrin repeat domain 6) Predicted to be involved in negative regulation of canonical Wnt signaling pathway and positive regulation of JNK cascade. Predicted to act upstream of or within positive regulation of Wnt signaling pathway, planar cell polarity pathway. Located in intracellular membrane-bounded organelle. [provided by Alliance of Genome Resources, Apr 2022]

(HGNC:):

ACMG classification

Verdict is Uncertain_significance. Variant got 2 ACMG points.

• PM2: Very rare variant in population databases, with high coverage

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
ANKRD6	NM_001242809.2	c.88A>C	p.Ile30Leu	missense_variant	2/16	ENST00000339746.9

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
ANKRD6	ENST00000339746.9	c.88A>C	p.Ile30Leu	missense_variant	2/16	1	NM_001242809.2	A1
	ENST00000438267.1			upstream_gene_variant		3

Frequencies

GnomAD3 genomes Cov.: 33

GnomAD4 exome Cov.: 30

GnomAD4 genome Cov.: 33

ClinVar

Significance: Uncertain significance

Submissions summary: Uncertain:1

Revision: criteria provided, single submitter

Submissions by phenotype

not specified Uncertain:1

Uncertain significance, criteria provided, single submitter

clinical testing

Ambry Genetics

Dec 17, 2021

The c.88A>C (p.I30L) alteration is located in exon 2 (coding exon 1) of the ANKRD6 gene. This alteration results from a A to C substitution at nucleotide position 88, causing the isoleucine (I) at amino acid position 30 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Uncertain	0.40
BayesDel_addAF	Uncertain	0.13	D
BayesDel_noAF	Uncertain	-0.050
CADD	Pathogenic	27
DANN	Uncertain	0.99
DEOGEN2	Benign	0.0047	.;T;.;.;T;.;T;.;T;T;T;.
Eigen	Uncertain	0.42
Eigen_PC	Uncertain	0.56
FATHMM_MKL	Pathogenic	0.99	D
LIST_S2	Uncertain	0.94	D;.;D;D;D;D;D;D;D;D;D;D
M_CAP	Benign	0.030	D
MetaRNN	Uncertain	0.58	D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM	Benign	-0.59	T
MutationAssessor	Benign	0.35	N;N;N;.;.;.;N;.;.;.;.;N
MutationTaster	Benign	1.0	D;D;D;D;D;D
PrimateAI	Pathogenic	0.85	D
PROVEAN	Benign	-0.97	N;N;N;N;N;N;N;N;N;N;N;N
REVEL	Benign	0.28
Sift	Benign	0.14	T;T;T;T;T;T;T;D;T;D;D;T
Sift4G	Benign	0.22	T;T;T;T;T;T;T;D;T;T;T;T
Polyphen		1.0	D;D;.;.;.;.;D;.;.;.;.;.
Vest4		0.73
MutPred		0.66		Loss of MoRF binding (P = 0.1174);Loss of MoRF binding (P = 0.1174);Loss of MoRF binding (P = 0.1174);Loss of MoRF binding (P = 0.1174);Loss of MoRF binding (P = 0.1174);Loss of MoRF binding (P = 0.1174);Loss of MoRF binding (P = 0.1174);Loss of MoRF binding (P = 0.1174);Loss of MoRF binding (P = 0.1174);Loss of MoRF binding (P = 0.1174);Loss of MoRF binding (P = 0.1174);Loss of MoRF binding (P = 0.1174);
MVP		0.51
MPC		0.22
ClinPred		0.85	D
GERP RS		5.9
Varity_R		0.17
gMVP		0.48

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.040		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr6-90276783;